Ophthalmic Comprehensive Reports

2020 Retinal Pharmaceuticals Market Report: A Global Analysis for 2019 to 2025, August, 2020

The 2020 Retinal Pharmaceuticals Market Report features new estimates that incorporate the impact of COVID-19 in 2020, an updated disease model based on disease prevalence by ethnicity, and updated estimations of severe NPDR. The report now discusses Beovu, biosimilars and relevant marketing agreements, gene therapy delivery methods and instruments, orally administered drug candidates in development, and eye drop retinal drug delivery. The 2020 report covers more development-stage programs, gene therapies, anti-inflammatories, sustained drug-delivery devices, and market competitors.

Related Reports

Want to Purchase the Full Report?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2020 Market Scope, LLC. All Rights reserved.